0001209191-20-036778.txt : 20200615
0001209191-20-036778.hdr.sgml : 20200615
20200615190941
ACCESSION NUMBER: 0001209191-20-036778
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200615
DATE AS OF CHANGE: 20200615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAHAM PETER J
CENTRAL INDEX KEY: 0001235635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 20964563
MAIL ADDRESS:
STREET 1: 315 E. 72ND ST.
STREET 2: APT 5E
CITY: NEW YORK
STATE: NY
ZIP: 10021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 100 PRINCETON SOUTH
STREET 2: SUITE 300
CITY: EWING
STATE: NJ
ZIP: 08628
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-11
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001235635
GRAHAM PETER J
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
0
1
0
0
EVP General Counsel, Secretary
Common Stock
2020-06-11
4
A
0
131868
2.73
A
517161
D
Common Stock
2020-06-13
4
F
0
15036
2.78
D
502125
D
Stock Option (right to buy)
2.73
2020-06-11
4
A
0
254165
0.00
A
2030-06-11
Common Stock
254165
254165
D
Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
/s/Keith Muckenhirn as attorney-in-fact for Peter J. Graham
2020-06-15